The Path
Built on the science.
Ready for the field.
MARS draws on three established modalities with substantial peer-reviewed literature: bilateral stimulation (the mechanism behind EMDR), paced respiration with extended exhale, and continuous biometric feedback. EMDR alone is endorsed by the World Health Organization, the American Psychiatric Association, and the International Society for Traumatic Stress Studies — whose gold-standard guidelines are built on 361 randomized controlled trials. Two separate military forces, working independently over 22 years, validated bilateral stimulation protocols across more than 17,900 cases. Our contribution is integrating all three modalities into a single field-deployable system, with novel voice-guided and biometric-adaptive protocols developed in-house.
Modality I
Bilateral Stimulation
Synchronized auditory and visual cues engaging both hemispheres of the brain — the mechanism underlying EMDR, with three decades of peer-reviewed efficacy research behind it.
Modality II
Paced Respiration
Slow, extended-exhale breathing with a fully understood physiological mechanism: the exhale activates the vagus nerve, directly triggering the parasympathetic nervous system — the body's off-switch for the stress response. Heart rate drops measurably during every exhale. Nasal breathing releases nitric oxide, acting as a vasodilator and improving oxygen delivery. Resonance frequency breathing produces significant, documented improvements in HRV, blood pressure, and cortisol — validated across forty years of clinical research, peer-reviewed studies at Columbia University, and the tactical breathing protocols used by Special Forces.
Modality III
Biometric Adaptation
Real-time sensing of cardiac, respiratory, and autonomic markers — closing the loop between what the body is doing and what the protocol delivers. The literature on biofeedback efficacy is mature; our integration is what's new.
Phase I-A · Now
Engineering complete. Protocols developed.
The Field Case is built. Voice-guided protocols and biometric-adaptive logic are validated against established modalities. Proof-of-concept deployments with vetted early users are underway.
Phase I-B · With Funding
Field hardware production. Pilot deployments.
Production runs of the Field Case, formalized pilot programs with crisis-response and reintegration partners, and clinical and field validation studies in collaboration with academic research centers.
Phase II · After I-B
New form factors complete. Daily resilience at scale.
Consumer-ready designs are complete and ready for staged release once Phase I deployment is operational. The science is the same; the form factor and the audience scale up. A growing body of grounding research extends the regulation thesis into daily life — a 2025 randomized double-blind trial in ScienceDirect linked earthing to measurable reductions in insomnia, perceived stress, and daytime sleepiness, with effects sustained at follow-up.
The Ask
We are seeking R&D capital, philanthropic partnerships, and government grant collaborators to bring Phase I to deployment. The market for what MARS does is enormous and the technology to do it is finally here — we want to make sure the people who need it most reach it before the people who need it least monetize it.
Detailed materials — including technical specifications, validation data, deployment partner letters of intent, milestone budgets, and IP status — are available under NDA upon qualified inquiry.
Active conversations with law enforcement family-services divisions, military reintegration programs, and academic clinical research centers. Inquiries from agencies, foundations, and aligned research institutions welcome through the channels below.